Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7518-7525

  Nowak, Martin A ^a   Lloyd, Alun L ^a   Vasquez, Gabriela M ^b   Wiltrout, Theresa A ^b   Wahl, Linda M ^a   Bischofberger, Norbert ^c   Williams, Jon ^d   Kinter, Audrey ^e   Fauci, Anthony S ^e   Hirsch, Vanessa M ^e   Lifson, Jeffrey D ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GILEAD SCIENCES   (United States)

^d Magamin Pharmaceuticals Inc   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; TENOFOVIR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HALF LIFE TIME; MATHEMATICAL MODEL; MONKEY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VACCINATION; VIREMIA; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0030756525     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7518-7525.1997     Document Type: Article

References (38)

1. Andersen, R. M., and R. M. May. 1991. Infectious diseases of humans. Oxford University Press, Oxford, United Kingdom.
2. Bonhoeffer, S., J. Coffin, and M. A. Nowak. 1997. Virus load and drug treatment. J. Virol. 71:3275-3278.
3. Bonhoeffer, S., R. M. May, G. M. Shaw, and M. A. Nowak. 1997. Virus dynamics and drug treatment. Proc. Natl. Acad. Sci. USA 94:6971-6976.
4. Cao, Y., D. D. Ho, J. Todd, R. Kokka, M. Urdea, J. D. Lifson, M. Piatak, S. Chen, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Clinical evaluation of branched DNA (bDNA) signal amplification for quantifying HIV-1 in human plasma. AIDS Res. Hum. Retroviruses 11:353-361.
5. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 267:483-489.
6. De Boer, R. J., and C. A. Boucher. 1996. Anti-CD4 therapy for AIDS suggested by mathematical models. Proc. R. Soc. Lond. B Biol. Sci. 263:899-905.
7. Goldstein, S., W. R. EIkins, W. T. London, A. Hahn, R. Goeken, J. E. Martin, and V. M. Hirsch. 1994. Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells. J. Med. Primatol. 23:75-82.
8. Grant, R. M., M. Kaur, H. A. McClure, A. Rosenthal, C. S. Horion, P. Carroll, R. P. Johnson, M. B. Feinberg, and S. I. Staprans. 1996. Plasma SIV dynamics during primary viremia, abstr. 46. In 14th Annual Symposium on Nonhuman Primate Models for AIDS, 23 to 26 October 1996, Portland Oreg.
9. Herz, A. V., S. Bonhoeffer, R. M. Anderson, R. M. May, and M. A. Nowak. 1996. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. Proc. Natl. Acad. Sci. USA 93:7247-7251.
10. Hirsch, V., D. Adger-Johnson, B. Campbell, S. Goldstein, C. Brown, W. R. Elkins, and D. C, Montefiori. 1997. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J. Virol. 71:1608-1620.
11. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, W. R. Elkins, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
12. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
13. Klotman, M. E., S. Y. Kim, A. Buchbinder, A. DeRossi, D. Baltimore, and F. Wong-Staal. 1991. Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus infection of lymphocytes and monocytes. Proc. Natl. Acad. Sci. USA 88:5011-5015.
14. Letvin, N., and N. King. 1990. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquired Immune Defic. Syndr. 3:1023-1040.
15. Lifson, J. D., M. Nowak, S. Goldstein, J. L. Rossio, A. Kinter, G. Vasquez. T. A. Wiltrout, C. Brown, D. Schneider, L. Wahl, A. Lloyd, W. R. Elkins, A. S. Fauci, and V. M. Hirsch. The extent of early viral replication is a critical determinant of the natural history of AIDS virus infection. Submitted for publication.
16. 15a. Lloyd, A. L., et al. Unpublished data.
17. Marx, P. A., A. I. Spira, A. Gettie, P. J. Dailey, R. S. Veazey, A. A. Lackner, C. J. Mahoney, C. J. Miller, L. E. Claypool, D. D. Ho, and N. J. Alexander, 1996, Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 2:1084-1089.
18. McLean, A. R., and M. A. Nowak. 1992. Competition between zidovudine sensitive and resistant strains of HIV. AIDS 6:71-79.
19. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 8:573-579.
20. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
21. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
22. Nowak, M. A., and C. R. M. Bangham. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74-79.
23. Nowak, M. A., S. Bonhoeffer, C. Loveday, P. Balfe, M. Semple, S. Kaye, M. Tennant-Flowers, and R. Tedder. 1995. HIV-1 dynamics: results confirmed. Nature 375:193.
24. Nowak, M. A., S. Bonhoeffer, G. M. Shaw, and R. M. May. 1997. Antiviral drug treatment: dynamics of resistance in free virus and infected cell populations. J. Theor. Biol. 184:203-217.
25. O'Brien, T., W. A. Blattner, D. Waters, E. Eyster, M. W. Hilgartner, A. R. Cohen, N. Luban, A. Hatzakis, L. M. Aledort, P. S. Rosenberg, W. J. Miley, B. L. Kroner, J. J. Goedert, et al. 1996. Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study. JAMA 276:105-110.
26. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life span, and viral generation time. Science 271:1582-1586.
27. Phillips, A. N. 1996. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271:497-499.
28. Piatak, M., K.-C. Luk, B. Williams, and J. D. Lifson. 1993. Quantitative competitive polymerase chain reaction (QC-PCR) for accurate quantitation of HIV DNA and RNA species. BioTechniques 14:70-77.
29. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
30. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A, Gallimore, and T. Corrah. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
31. Rowland-Jones, S. L., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Opin. Immunol. 7:448-455.
32. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21-24.
33. Stilianakis, N. I., C. A. Boucher, M. D. De Jong, R. Van Leeuwen, R. Schuurman, and R. J. DeBoer. 1997. Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model. J. Virol. 71:161-168.
34. Travis, B. M., A. Watson, J. Ranchalis, N. L. Haigwood, and S. L. Hu. 1996. Comparative QC-PCR analysis of viral load in macaques infected by primate lentiviruses: plasma SIV dynamics during primary viremia, abstr. 119. In 13th Annual Symposium on Nonhuman Primate Models for AIDS, 5 to 8 November 1996, Monterey, Calif.
35. Tsai, C.-C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. E. Benveniste, and R. Black. 1995. Prevention of SIV infection by R-9-(2-phosphonylmethoxyproply)adenine et al. Science 270:1197-1199.
36. Van Genien, B., P. van der Wiel, R. van Beuningen, P. Sillekens, S. Jurriaans, C. Dries, R. Schoones, and T. Kievits. 1995. The one tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods Appl. 4:S177-S184.
37. Watson, A., J. Ranchalis, B. Travis, J. McClure, W. Sutton, P. R. Johnson, S.-L. Hu, and N. L. Haigwood. 1997. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival J. Virol 71:284-290.
38. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoefler, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.